Approval · Notice of Compliance 23866 · 2020
PROLEUKIN: Notice of Compliance 23866
Issued July 6, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23866
- Date
- July 6, 2020
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Change in Product Ownership & Administrative- DIN transfer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | Not yet assigned | — |
Medicinal ingredients
- ALDESLEUKIN 22,000,000 UNIT per VIAL